Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase.
Dervieux
T
T
Unité de Pharmacologie Pédiatrique, Hôpital Robert Debre, Paris, France.
Médard
Y
Y
Baudouin
V
V
Maisin
A
A
Zhang
D
D
Loirat
C
C
Jacqz-Aigrain
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006084:Graft Rejection / Q000097:blood / Q000201:enzymology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008780:Methyltransferases / Q000097:blood*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine